用生物药物治疗过敏性支气管肺性阿斯伯吉洛症
Koichiro Asano1, Katsuyoshi Tomomatsu1, Naoki Okada1
1Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa 2591193, Japan.
Chinese medical journal pulmonary and critical care medicine
|April 14, 2025
概括
过敏性支气管肺性阿斯伯吉洛症 (ABPA) 在治疗后经常复发. 像奥马利祖马布,梅波利祖马布和本拉利祖马布这样的生物药物在治疗耐火性ABPA和减少类固醇依赖方面表现有前途.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 过敏性支气管肺性阿斯伯吉洛症 (ABPA) 是一种肺部疾病,通常用皮质类固醇和抗真菌药物治疗.
- 在标准治疗后,大约一半的患者出现了ABPA的复发,需要替代疗法.
- 长期使用皮质类固醇会产生不良影响,这促使人们寻找向治疗方法.
研究的目的:
- 审查生物制剂在治疗耐火性过敏性支气管肺炎阿斯伯吉洛症方面的疗效.
- 评估生物制剂在减少类固醇依赖和改善ABPA患者临床结果方面的作用.
主要方法:
- 对ABPA生物疗法的当前文献的综述.
- 对评估抗IgE,抗乙烯酸和其他2型免疫向生物制剂的研究进行分析.
- 检查临床试验数据和病例报告对dupilumab和tezepelumab在ABPA.
主要成果:
- 奥马利祖马布,梅波利祖马布和本拉利祖马布在减少喘恶化和ABPA中的皮质类固醇剂量方面已经证明有效.
- 梅波利祖马布和本拉利祖马布在放射性异常方面有所改善,包括支气管粘液塞.
- 有限的数据表明dupilumab和tezepelumab在治疗耐药病例中的潜在疗效.
结论:
- 生物疗法为耐火性ABPA患者提供了有价值的替代方案,改善了症状控制,减少了对皮质类固醇的依赖.
- 需要进一步的研究来确定生物制剂在预防ABPA复发和恶化中的作用.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
174
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
174
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
133
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
133
01:17Drugs Used in Lower Respiratory Disorders: Overview
260
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
260
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
147
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
147
01:20Asthma: Pathogenesis and Management
245
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
245